Search
Search
About
Log in
Join
Experiences with
Clinical trials
Posts
Communities
16,470 public posts
Filter results
Hope Biosciences Stem Cell Trial
I am participating in the clinical trial of mesenchymal stem cells at Hope Biosciences in Houston, Texas. I am Patient 54 out of 60 they plan to enroll. I had my first infusion yesterday, with no obvious concerns or ill effects. As my treatments progress, I would like to privately compare notes with
I am participating in the clinical trial of mesenchymal stem cells at Hope Biosciences in Houston, Texas. I am Patient 54 out of 60 they plan to enroll. I had my first infusion yesterday, with no obvious concerns or ill effects. As my treatments progress, I would like to privately compare notes with
jimcaster
in
Cure Parkinson's
4 months ago
Ambroxol update
Sadly such delays are common for
clinical
trials
of such size and complexity. Rest assured that we are doing everything we can to help expedite the process and we hope to have further and better news for you soon. We remain committed to seeing ambroxol tested further in Parkinson’s.
Sadly such delays are common for
clinical
trials
of such size and complexity. Rest assured that we are doing everything we can to help expedite the process and we hope to have further and better news for you soon. We remain committed to seeing ambroxol tested further in Parkinson’s.
CuriousMe12
in
Cure Parkinson's
10 months ago
Promising treatments in the 2023 Parkinson's clinical trials pipeline
https://www.parkinson.ca/promising-treatments-in-the-2023-parkinsons-
clinical
-
trials
/ "Phase 3 DMT trials completing in 2023: Memantine : Alzheimer's drug that aims to reduce cognitive impairment in Parkinson's.
https://www.parkinson.ca/promising-treatments-in-the-2023-parkinsons-
clinical
-
trials
/ "Phase 3 DMT trials completing in 2023: Memantine : Alzheimer's drug that aims to reduce cognitive impairment in Parkinson's.
nednedned
in
Cure Parkinson's
1 year ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Next NoSilverBullet Zoom webinar on 13th of November: Interview of Dr Wayne Markman, CEO of Symbyx, on "Light therapy for Parkinson's".
By next year, SYMBYX will have completed 4
clinical
trials
with publications in leading peer reviewed journals and commenced 3 additional large scale randomised control trials investigating motor, non-motor and medication efficacy implications of infrared laser treatment to the gut.
By next year, SYMBYX will have completed 4
clinical
trials
with publications in leading peer reviewed journals and commenced 3 additional large scale randomised control trials investigating motor, non-motor and medication efficacy implications of infrared laser treatment to the gut.
Michel0220
in
Cure Parkinson's
1 year ago
FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy - Applies to all approved therapies, but benefits still outweigh risks
[/i] [i]According to an FDA spokesperson, the agency has received 19 reports of CAR-associated T-cell malignancies, five from
clinical
trials
and 14 from the FDA's adverse event reporting system.
[/i] [i]According to an FDA spokesperson, the agency has received 19 reports of CAR-associated T-cell malignancies, five from
clinical
trials
and 14 from the FDA's adverse event reporting system.
cujoe
in
CLL Support
10 months ago
LET'S TALK CLL- Patients & Doctors Discuss the Latest Live! SATURDAY, OCTOBER 14, 2023 Virtual program starts at 10am CDT 11am EDT
Adam Kittai, MD from The OSU, and Jackie Broadway-Duren, PhD, DNP, APRN, FNP-BC from MD Anderson gather to share the latest in CLL research,
clinical
trials
, treatments, and comprehensive care strategies.
Adam Kittai, MD from The OSU, and Jackie Broadway-Duren, PhD, DNP, APRN, FNP-BC from MD Anderson gather to share the latest in CLL research,
clinical
trials
, treatments, and comprehensive care strategies.
lankisterguy
Volunteer
in
CLL Support
1 year ago
CRISPR: not PCa but cold solid tumors related!
I have the feeling that this is the first CRISPR based cancer therapy to reach clinical trial phase…great! I looooove CRISPR! https://www.insideprecisionmedicine.com/topics/oncology/goldeneye-ksq-doses-first-solid-tumor-patient-with-crispr-cas9-etils/
I have the feeling that this is the first CRISPR based cancer therapy to reach clinical trial phase…great! I looooove CRISPR! https://www.insideprecisionmedicine.com/topics/oncology/goldeneye-ksq-doses-first-solid-tumor-patient-with-crispr-cas9-etils/
Maxone73
in
Advanced Prostate Cancer
4 months ago
Is it just me?
I am looking forward to these meds finishing
clinical
trials
: * Vidofludimus calcium [It's both anti-EBV and neuroprotective effect] (Link: https://multiplesclerosisnewstoday.com/news-posts/2023/03/07/actrims-2023-vidofludimus-calcium-rrms-offers-safety-efficacy/#:~:text=Previously%20known
I am looking forward to these meds finishing
clinical
trials
: * Vidofludimus calcium [It's both anti-EBV and neuroprotective effect] (Link: https://multiplesclerosisnewstoday.com/news-posts/2023/03/07/actrims-2023-vidofludimus-calcium-rrms-offers-safety-efficacy/#:~:text=Previously%20known
By-Design-1000
in
My MSAA Community
6 months ago
Share your experiences of clinical trials
LUPUS UK are planning to develop a range of new information resources sharing the experiences of people who have participated in
clinical
trials
and we want to hear from you!
LUPUS UK are planning to develop a range of new information resources sharing the experiences of people who have participated in
clinical
trials
and we want to hear from you!
Debbie_kinsey
Administrator
in
LUPUS UK
1 year ago
Terbium-161 - As a follow-up to Alicia Morgan's comments in the PeterMac GUcast interview posted earlier by marnie46.
I meant to include this article, a 24 Nov 2023 news release on Terbium-161, in a followup reply to Marnie's post of the Dr. Morgan interview by the excellent PeterMac team several days back. [i]
Three big challenges in metastatic prostate cancer | Dr Alicia Morgans
[/i] [i]
https://healthunlocked.com
I meant to include this article, a 24 Nov 2023 news release on Terbium-161, in a followup reply to Marnie's post of the Dr. Morgan interview by the excellent PeterMac team several days back. [i]
Three big challenges in metastatic prostate cancer | Dr Alicia Morgans
[/i] [i]
https://healthunlocked.com
cujoe
in
Fight Prostate Cancer
4 months ago
Try the Clinical Trial Navigator on ChatGPT
It will be super helpful if you test out the
Clinical
Trial Navigator on ChatGPT Please search for
trials
that interest you, and let me know how useful the results were. You'll need the $20/month version of ChatGPT to use this. https://chat.openai.com/g/g-rl6cvjdon-clinical-trial-navigator
It will be super helpful if you test out the
Clinical
Trial Navigator on ChatGPT Please search for
trials
that interest you, and let me know how useful the results were. You'll need the $20/month version of ChatGPT to use this. https://chat.openai.com/g/g-rl6cvjdon-clinical-trial-navigator
Darryl
Partner
in
Advanced Prostate Cancer
9 months ago
Phase 1/2 ARV-766 clinical trial
“The purpose of this study is to assess the safety and tolerability (good and bad effects) and how prostate cancer responds to two different doses of the investigational study drug (ARV-766) in combination with Abiraterone in men with metastatic cRPC who have not received prior novel hormonal therapies
“The purpose of this study is to assess the safety and tolerability (good and bad effects) and how prostate cancer responds to two different doses of the investigational study drug (ARV-766) in combination with Abiraterone in men with metastatic cRPC who have not received prior novel hormonal therapies
Woodman33
in
Advanced Prostate Cancer
4 months ago
FDA Greenlights Phase 2/3 Trial of KPG-121/Abiraterone in mCRPC
A clinical trial to evaluate the combination of a new drug called KPG-121 with abiraterone acetate (Zytiga) for treating metastatic castration-resistant prostate cancer (mCRPC) as a first-line therapy has been approved by the FDA. KPG-121 is an investigational drug that targets specific proteins involved
A clinical trial to evaluate the combination of a new drug called KPG-121 with abiraterone acetate (Zytiga) for treating metastatic castration-resistant prostate cancer (mCRPC) as a first-line therapy has been approved by the FDA. KPG-121 is an investigational drug that targets specific proteins involved
God_Loves_Me
in
Advanced Prostate Cancer
4 months ago
Ipsen and IRLAB enter exclusive worldwide licensing agreement aimed to improve the lives of people living with Parkinson’s disease
Mesdopetam is being assessed in Phase IIb
clinical
trials
as a potential treatment option for people living with Parkinson’s disease (PD) experiencing levodopa-induced dyskinesia (LID).
Mesdopetam is being assessed in Phase IIb
clinical
trials
as a potential treatment option for people living with Parkinson’s disease (PD) experiencing levodopa-induced dyskinesia (LID).
Farooqji
in
Cure Parkinson's
1 year ago
pleural effusion
hi all you very supportive ladies . 4 years since my diagnosis with stage 3 ovarian cancer I have had all the chemo combinations available plus Avastin and PARP inhibitors . I was then in a clinical trial for a year which had a small effect and finished in March. a couple of weeks ago , I was admitted
hi all you very supportive ladies . 4 years since my diagnosis with stage 3 ovarian cancer I have had all the chemo combinations available plus Avastin and PARP inhibitors . I was then in a clinical trial for a year which had a small effect and finished in March. a couple of weeks ago , I was admitted
Lookingahead
in
My Ovacome
4 months ago
Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting
As part of the ISCT 2024 Translational Pathway Sessions, as well as the ISCT main program, Aspen's Chief Scientific Officer Xiaokui Zhang, Ph.D., and Chief Technology Officer Kim Raineri will discuss developments in autologous research and development, including for ANPD001, Aspen's autologous iPSC-derived
As part of the ISCT 2024 Translational Pathway Sessions, as well as the ISCT main program, Aspen's Chief Scientific Officer Xiaokui Zhang, Ph.D., and Chief Technology Officer Kim Raineri will discuss developments in autologous research and development, including for ANPD001, Aspen's autologous iPSC-derived
Farooqji
in
Cure Parkinson's
4 months ago
News from Malecare and OpenAI
Today, GPTs in the Store are now available to all ChatGPT users, allowing more than 100 million weekly active users to experience Cancer Copilot, Clinical Trial Navigator and the others in the store for free. Also, GPTs now use the newest flagship model, GPT-4o. Here are direct links: https://chatgpt.com
Today, GPTs in the Store are now available to all ChatGPT users, allowing more than 100 million weekly active users to experience Cancer Copilot, Clinical Trial Navigator and the others in the store for free. Also, GPTs now use the newest flagship model, GPT-4o. Here are direct links: https://chatgpt.com
Darryl
Partner
in
Prostate Cancer Network
4 months ago
news from Malecare and OpenAI
Today, GPTs in the Store are now available to all ChatGPT users, allowing more than 100 million weekly active users to experience Cancer Copilot, Clinical Trial Navigator and the others in the store for free. Also, GPTs now use the newest flagship model, GPT-4o. Here are direct links: https://chatgpt.com
Today, GPTs in the Store are now available to all ChatGPT users, allowing more than 100 million weekly active users to experience Cancer Copilot, Clinical Trial Navigator and the others in the store for free. Also, GPTs now use the newest flagship model, GPT-4o. Here are direct links: https://chatgpt.com
Darryl
Partner
in
Advanced Prostate Cancer
4 months ago
Interactive seminar on Garvan institute's work to improve the treatment of advanced cancers, including myeloma, breast and prostate cancer
Garvan Institute of Medical Research Free Public Seminar - Giving cancer no place to hide SPEAKER/S Professor Peter Croucher and Associate Professor Christine Chaffer DATE 10:30am 21 Jun 2024— 11:30am 21 Jun 2024 (AEST) Join us for an interactive seminar on Garvan’s work to improve the treatment
Garvan Institute of Medical Research Free Public Seminar - Giving cancer no place to hide SPEAKER/S Professor Peter Croucher and Associate Professor Christine Chaffer DATE 10:30am 21 Jun 2024— 11:30am 21 Jun 2024 (AEST) Join us for an interactive seminar on Garvan’s work to improve the treatment
Seasid
in
Advanced Prostate Cancer
4 months ago
Allopregnanolone as a Regenerative Treatment for Parkinson's Disease (Allo-PD)
I just happened upon this trial and it is something I had never heard of. It looks like a very small trial being conducted in Tucson, AZ. https://clinicaltrials.gov/study/NCT06263010?locStr=Arizona&country=United%20States&state=Arizona&cond=Parkinson%20disease&aggFilters=status:not%20rec&rank=2 Detailed
I just happened upon this trial and it is something I had never heard of. It looks like a very small trial being conducted in Tucson, AZ. https://clinicaltrials.gov/study/NCT06263010?locStr=Arizona&country=United%20States&state=Arizona&cond=Parkinson%20disease&aggFilters=status:not%20rec&rank=2 Detailed
Boscoejean
in
Cure Parkinson's
4 months ago
1
...
14
15
16
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Atrial Fibrillation Support
4312 results
Anxiety and Depression Support
2567 results
Advanced Prostate Cancer
1451 results
View top 10 communities
Sort by
Most Relevant
Newest